INVA Competitors & Alternatives
Compare Innoviva Inc with similar stocks in the same industry
Biotechnology
INVA
Main Stock$21.74
Tradestie Score
59
Market Cap
$1.15B
P/E Ratio
3.6
Revenue Growth
0.1%
Analyst Upside
+63.3%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$19.08
|
$1.74B | - | 61 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$38.17
|
$1.68B | - | 62 | Compare |
|
MPLT
MPLT
|
$37.91
|
$1.66B | - | 63 | Compare |
|
MNKD
Mannkind Corporation
|
$3.88
|
$1.65B | - | 54 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$39.73
|
$1.63B | - | 54 | Compare |
|
BHVN
Biohaven Ltd.
|
$14.94
|
$1.57B | - | 59 | Compare |
|
VCEL
Vericel Corporation
|
$46.09
|
$1.56B | 109.3 | 62 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$101.28
|
$1.55B | - | 60 | Compare |
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$34.81
|
$1.55B | 14.9 | 55 | Compare |
|
PHVS
Pharvaris N.V. Ordinary Shares
|
$34.42
|
$1.55B | - | 60 | Compare |
More INVA Analysis
Data updated: Jul 14, 2026 | Industry: Biotechnology (SIC 2834)
231 stocks in this industry